NO329470B1 - Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter - Google Patents
Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter Download PDFInfo
- Publication number
- NO329470B1 NO329470B1 NO20013605A NO20013605A NO329470B1 NO 329470 B1 NO329470 B1 NO 329470B1 NO 20013605 A NO20013605 A NO 20013605A NO 20013605 A NO20013605 A NO 20013605A NO 329470 B1 NO329470 B1 NO 329470B1
- Authority
- NO
- Norway
- Prior art keywords
- warts
- treatment
- preparation
- formic acid
- wart
- Prior art date
Links
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 title claims description 43
- 238000011282 treatment Methods 0.000 title claims description 35
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 title claims description 21
- 235000019253 formic acid Nutrition 0.000 title claims description 21
- 239000003814 drug Substances 0.000 title claims description 8
- 239000000203 mixture Substances 0.000 title claims description 3
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 238000009472 formulation Methods 0.000 title 1
- 208000000260 Warts Diseases 0.000 claims description 74
- 201000010153 skin papilloma Diseases 0.000 claims description 74
- 238000002360 preparation method Methods 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 4
- 241001631646 Papillomaviridae Species 0.000 claims description 4
- 238000011200 topical administration Methods 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 description 9
- 241000700605 Viruses Species 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9900177A SE513436C2 (sv) | 1999-01-21 | 1999-01-21 | Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus |
| PCT/SE2000/000088 WO2000045808A1 (en) | 1999-01-21 | 2000-01-18 | Preparation for warts |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20013605D0 NO20013605D0 (no) | 2001-07-20 |
| NO20013605L NO20013605L (no) | 2001-09-20 |
| NO329470B1 true NO329470B1 (no) | 2010-10-25 |
Family
ID=20414173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013605A NO329470B1 (no) | 1999-01-21 | 2001-07-20 | Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6503946B1 (sv) |
| EP (1) | EP1143966B1 (sv) |
| AT (1) | ATE249820T1 (sv) |
| AU (1) | AU2337900A (sv) |
| DE (1) | DE60005299T2 (sv) |
| ES (1) | ES2207486T3 (sv) |
| NO (1) | NO329470B1 (sv) |
| SE (1) | SE513436C2 (sv) |
| WO (1) | WO2000045808A1 (sv) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7128903B2 (en) | 2001-10-03 | 2006-10-31 | Innovative Pharmaceutical Concepts (Ipc) Inc. | Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same |
| BG106215A (bg) * | 2001-12-12 | 2003-06-30 | ПАНЧЕВ Владимир | Средство за радикално лечение на туморите, възпалителни процеси, гъбични образувания и други изменения на тъканите, диагностика и профилактика и методи за прилагането му |
| ES2561814T3 (es) * | 2010-09-17 | 2016-03-01 | Abbell Ab | Tratamiento de infecciones micóticas |
| ES2658287T3 (es) * | 2010-12-06 | 2018-03-09 | Abbex Ab | Composición para el tratamiento de verrugas |
| UA111785C2 (uk) * | 2012-05-28 | 2016-06-10 | А-Б-Б-Е-Кс Аб | Композиція для лікування бородавок та спосіб лікування бородавок |
| EP2692332B1 (en) * | 2012-05-29 | 2019-08-21 | Unigroup ApS | Composition for the treatment of callus, corns and psoriasis |
| FR3018687B1 (fr) * | 2014-03-19 | 2017-04-14 | Patrick Lepeytre | " composition a base d'acides carboxyliques et son application pour le traitement des hyperkeratoses " - |
| EP3205340A1 (en) * | 2016-02-10 | 2017-08-16 | Winko Beheer B.V. | Composition for treating skin disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU86573A1 (de) * | 1986-09-08 | 1988-04-05 | Chimicasa Gmbh | Verfahren und praeparat zum inaktivieren von viren innerhalb lebender menschlicher oder tierischer organismen |
| EP0527241B1 (de) | 1991-07-15 | 1994-03-16 | Artesan Pharma Gesellschaft mit beschränkter Haftung | Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich |
| GB9621990D0 (en) * | 1996-10-22 | 1996-12-18 | Scotia Pharma Ltd | Use |
| DE19736265C2 (de) | 1997-08-15 | 2002-10-31 | Phytexpert Pharm Tox Consultin | Arzneimittel zur Behandlung von Hauterkrankungen |
-
1999
- 1999-01-21 SE SE9900177A patent/SE513436C2/sv not_active IP Right Cessation
-
2000
- 2000-01-18 AU AU23379/00A patent/AU2337900A/en not_active Abandoned
- 2000-01-18 US US09/889,740 patent/US6503946B1/en not_active Expired - Lifetime
- 2000-01-18 WO PCT/SE2000/000088 patent/WO2000045808A1/en active IP Right Grant
- 2000-01-18 EP EP00902251A patent/EP1143966B1/en not_active Expired - Lifetime
- 2000-01-18 AT AT00902251T patent/ATE249820T1/de not_active IP Right Cessation
- 2000-01-18 ES ES00902251T patent/ES2207486T3/es not_active Expired - Lifetime
- 2000-01-18 DE DE60005299T patent/DE60005299T2/de not_active Expired - Lifetime
-
2001
- 2001-07-20 NO NO20013605A patent/NO329470B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1143966B1 (en) | 2003-09-17 |
| DE60005299D1 (de) | 2003-10-23 |
| ATE249820T1 (de) | 2003-10-15 |
| SE9900177L (sv) | 2000-07-22 |
| ES2207486T3 (es) | 2004-06-01 |
| SE513436C2 (sv) | 2000-09-11 |
| AU2337900A (en) | 2000-08-25 |
| SE9900177D0 (sv) | 1999-01-21 |
| DE60005299T2 (de) | 2004-07-01 |
| NO20013605L (no) | 2001-09-20 |
| WO2000045808A1 (en) | 2000-08-10 |
| US6503946B1 (en) | 2003-01-07 |
| EP1143966A1 (en) | 2001-10-17 |
| NO20013605D0 (no) | 2001-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5411738A (en) | Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine | |
| US5709869A (en) | Method for treating nerve injury pain associated with shingles | |
| Gajraj et al. | Eutectic mixture of local anesthetics (EMLA®) cream | |
| RU2523889C2 (ru) | Применение фармацевтических композиций в изготовлении лекарственных средств для лечения диабетических язв | |
| Artzi et al. | A new approach in the treatment of pediatric hypertrophic burn scars: Tixel‐associated topical triamcinolone acetonide and 5‐fluorouracil delivery | |
| Martini et al. | Efficacy and Tolerability of Fitostimoline in Two Different Forms (Soaked Gauzes and Cream) and Citrizan Gel in the Topical Treatment of Second‐Degree Superficial Cutaneous Burns | |
| McShane et al. | Treatment of hypergranulation tissue with high potency topical corticosteroids in children | |
| NO329470B1 (no) | Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter | |
| Anantharaj et al. | A comparative evaluation of pain perception following topical application of benzocaine gel, clove-papaya based anesthetic gel and precooling of the injection site before intraoral injections in children | |
| US20230390176A1 (en) | Cosmetic Skin and Medical Cream | |
| CN102293783B (zh) | 一种治疗褥疮的中药组合物 | |
| Kawalilak et al. | Management of a facial partial thickness chemical burn in a dog caused by bleach | |
| Dhlamini et al. | Clinical Effect of Photobiomodulation on Wound Healing of Diabetic Foot Ulcers: Does Skin Color Needs to Be Considered? | |
| KM et al. | Combined phototherapy/low intensity laser therapy in the management of diabetic ischaemic and neuropathic ulceration: a single case series investigation | |
| RU2467719C2 (ru) | Способ лечения невралгии тройничного нерва | |
| US6395779B1 (en) | Method of treatment using peroxidized lipids | |
| RU2286791C1 (ru) | Способ лечения рубцов | |
| Schmidt | Warts: their diagnosis and treatment | |
| Hussain et al. | Treatment options for managing non‐genital warts | |
| Mudakappagol et al. | An Ayurvedic Management of Chronic Nonhealing Ulcer in Buerger’s Disease wsr to gambhīra vātarakta: A Case Study | |
| Mohamed et al. | Evaluation of the Curative Effect of Topical Insulin Application on Burn Wounds of Non-Diabetic Patients with Minor to Moderate Partial Thickness Burns | |
| Bihari et al. | Assessment of the Effectiveness of Jalaukavacharana (Leech therapy) and Shalmali Kantaka Lepa in a Mukhadushika (Acne Vulgaris): A Case Study | |
| Senthiarasi | Ayurvedic management of Agnidagdha vrana (burn wound) in a child: A case report | |
| JPS6257566A (ja) | 水虫治療用塗布剤 | |
| Curtis | Initial management of the burn wound patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees | ||
| BDEC | Board of appeal decision |
Free format text: KLAGEN FORKASTES Effective date: 20151012 |